Zynex (ZYXI) Competitors $1.55 0.00 (0.00%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$1.54 -0.02 (-0.97%) As of 09/19/2025 06:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZYXI vs. NYXH, SPAI, LNSR, LAKE, INO, PROF, RCEL, LUCD, HYPR, and PDEXShould you be buying Zynex stock or one of its competitors? The main competitors of Zynex include Nyxoah (NYXH), Safe Pro Group (SPAI), LENSAR (LNSR), Lakeland Industries (LAKE), Inovio Pharmaceuticals (INO), Profound Medical (PROF), Avita Medical (RCEL), Lucid Diagnostics (LUCD), Hyperfine (HYPR), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry. Zynex vs. Its Competitors Nyxoah Safe Pro Group LENSAR Lakeland Industries Inovio Pharmaceuticals Profound Medical Avita Medical Lucid Diagnostics Hyperfine Pro-Dex Zynex (NASDAQ:ZYXI) and Nyxoah (NASDAQ:NYXH) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Which has better earnings & valuation, ZYXI or NYXH? Zynex has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Zynex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZynex$192.35M0.24$2.99M-$0.94-1.65Nyxoah$4.93M34.11-$64.10M-$2.30-2.15 Is ZYXI or NYXH more profitable? Zynex has a net margin of -19.79% compared to Nyxoah's net margin of -1,541.84%. Zynex's return on equity of -78.54% beat Nyxoah's return on equity.Company Net Margins Return on Equity Return on Assets Zynex-19.79% -78.54% -16.70% Nyxoah -1,541.84%-79.18%-54.92% Which has more risk and volatility, ZYXI or NYXH? Zynex has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500. Comparatively, Nyxoah has a beta of 1.6, indicating that its stock price is 60% more volatile than the S&P 500. Does the media favor ZYXI or NYXH? In the previous week, Nyxoah had 3 more articles in the media than Zynex. MarketBeat recorded 3 mentions for Nyxoah and 0 mentions for Zynex. Zynex's average media sentiment score of 0.00 beat Nyxoah's score of -0.28 indicating that Zynex is being referred to more favorably in the media. Company Overall Sentiment Zynex Neutral Nyxoah Neutral Do analysts rate ZYXI or NYXH? Zynex presently has a consensus target price of $4.90, suggesting a potential upside of 216.13%. Nyxoah has a consensus target price of $15.00, suggesting a potential upside of 203.64%. Given Zynex's higher probable upside, equities analysts plainly believe Zynex is more favorable than Nyxoah.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zynex 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Nyxoah 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of ZYXI or NYXH? 29.7% of Zynex shares are owned by institutional investors. 49.3% of Zynex shares are owned by company insiders. Comparatively, 17.1% of Nyxoah shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryZynex beats Nyxoah on 11 of the 16 factors compared between the two stocks. Get Zynex News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYXI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZYXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZYXI vs. The Competition Export to ExcelMetricZynexMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$46.96M$10.74B$5.80B$10.40BDividend YieldN/A1.88%5.63%4.60%P/E Ratio-1.6521.6480.5826.78Price / Sales0.2431.96534.44123.53Price / Cash6.3524.5037.9961.55Price / Book1.383.4215.776.40Net Income$2.99M$210.63M$3.30B$271.80M7 Day Performance4.73%-0.02%5.36%3.49%1 Month Performance0.65%1.47%8.10%9.90%1 Year Performance-80.91%-9.87%81.36%28.62% Zynex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZYXIZynex1.845 of 5 stars$1.55flat$4.90+216.1%-81.4%$46.96M$192.35M-1.65770NYXHNyxoah2.2553 of 5 stars$4.77-9.0%$15.00+214.5%-42.6%$178.48M$4.89M-2.07110High Trading VolumeSPAISafe Pro Group3.3084 of 5 stars$7.41-6.8%$10.50+41.7%+137.2%$149.56M$2.17M-9.2611Upcoming EarningsAnalyst RevisionLNSRLENSAR1.3947 of 5 stars$12.34-1.0%$15.00+21.6%+187.2%$148.83M$53.49M-2.93110Positive NewsLAKELakeland Industries4.8218 of 5 stars$14.49-1.0%$25.00+72.5%-26.8%$140.02M$167.21M-5.292,100News CoverageAnalyst UpgradeShort Interest ↓Analyst RevisionINOInovio Pharmaceuticals3.4367 of 5 stars$2.28-4.2%$8.80+286.0%-65.6%$126.48M$220K-0.87320PROFProfound Medical1.4738 of 5 stars$4.09+1.2%$11.00+168.9%-44.6%$121.69M$10.68M-2.80150News CoverageRCELAvita Medical2.4061 of 5 stars$6.76+48.2%$11.60+71.6%-49.5%$121.38M$64.25M-3.43130High Trading VolumeLUCDLucid Diagnostics2.9447 of 5 stars$1.06+2.9%$3.65+244.3%+33.1%$111.73M$4.35M-0.8970Analyst DowngradeGap UpHYPRHyperfine0.9682 of 5 stars$1.39-2.1%$1.28-7.7%+39.4%$111.58M$12.89M-2.67190PDEXPro-Dex2.5638 of 5 stars$32.62-1.4%$56.00+71.7%+24.4%$107.87M$66.59M12.08140 Related Companies and Tools Related Companies Nyxoah Alternatives Safe Pro Group Alternatives LENSAR Alternatives Lakeland Industries Alternatives Inovio Pharmaceuticals Alternatives Profound Medical Alternatives Avita Medical Alternatives Lucid Diagnostics Alternatives Hyperfine Alternatives Pro-Dex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZYXI) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynex Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
